Millennium Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.5M | Sell |
1,483,724
-150,263
| -9% | -$557K | ﹤0.01% | 2017 |
|
|
2025
Q1 | $5.28M | Buy |
1,633,987
+213,264
| +15% | +$689K | ﹤0.01% | 1935 |
|
|
2024
Q4 | $7.91M | Buy |
1,420,723
+1,337,497
| +1,607% | +$7.45M | ﹤0.01% | 1727 |
|
|
2024
Q3 | $900K | Buy |
83,226
+49,382
| +146% | +$534K | ﹤0.01% | 2986 |
|
|
2024
Q2 | $710K | Buy |
33,844
+22,400
| +196% | +$470K | ﹤0.01% | 3054 |
|
|
2024
Q1 | $365K | Buy |
+11,444
| New | +$365K | ﹤0.01% | 3429 |
|
|
2023
Q4 | – | Sell |
-331,516
| Closed | -$4.22M | – | 4226 |
|
|
2023
Q3 | $4.22M | Buy |
331,516
+52,815
| +19% | +$672K | ﹤0.01% | 1994 |
|
|
2023
Q2 | $5.04M | Buy |
+278,701
| New | +$5.04M | ﹤0.01% | 1936 |
|
|
2023
Q1 | – | Sell |
-287,483
| Closed | -$6.39M | – | 4663 |
|
|
2022
Q4 | $6.39M | Buy |
287,483
+27,374
| +11% | +$608K | ﹤0.01% | 1951 |
|
|
2022
Q3 | $2.09M | Sell |
260,109
-14,319
| -5% | -$115K | ﹤0.01% | 2833 |
|
|
2022
Q2 | $1.92M | Buy |
274,428
+197,504
| +257% | +$1.38M | ﹤0.01% | 2929 |
|
|
2022
Q1 | $1.16M | Buy |
+76,924
| New | +$1.16M | ﹤0.01% | 3481 |
|
|
2021
Q4 | – | Sell |
-155,258
| Closed | -$4.19M | – | 5319 |
|
|
2021
Q3 | $4.19M | Sell |
155,258
-196,793
| -56% | -$5.31M | ﹤0.01% | 2356 |
|
|
2021
Q2 | $8.48M | Buy |
352,051
+17,902
| +5% | +$431K | 0.01% | 1590 |
|
|
2021
Q1 | $14.5M | Sell |
334,149
-10,134
| -3% | -$440K | 0.01% | 1063 |
|
|
2020
Q4 | $14.3M | Buy |
+344,283
| New | +$14.3M | 0.01% | 1023 |
|